Diagnostic Testing and Treatment Guidelines for COVID-19 and Influenza

Details

• Personal Author:
  Patel, Pragna ; Uyeki, Tim
• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. ; National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. ; Center for Preparedness and Response (U.S.)
• Description:
  Thursday, February 1, 2024
  
  Diagnostic testing for SARS-CoV-2 and influenza viruses can guide clinical management, including appropriate antiviral treatment, particularly in persons at higher risk for progression to severe disease from COVID-19 and influenza, regardless of vaccination status. Antivirals are available that can reduce the risk of severe illness and death from COVID-19 and mitigate influenza illness. During this COCA Call, subject matter experts will present an overview of COVID-19 and influenza therapeutic options, including eligibility, indications, and efficacy.
  
  020124_slides.pdf
  
  COVID-19 Diagnosis and Treatment / Pragna Patel -- Influenza Activity and Disease Burden / Tim Uyeki.
  
  
• Subjects:
  COVID-19 COVID-19 Testing COVID-19 Vaccines Influenza, Human Influenza Vaccines
• Series:
  Clinician Outreach and Communication Activity (COCA) Webinar
• Document Type:
  Text
• Genre:
  Presentation
• Place as Subject:
  United States
• Pages in Document:
  64 unnumbered slides
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:4f47da04792e889e124895280b4578596a806ad417b57ec8295fa66a7172003ad863df91a8f526ad09259aa9ba3bc797d058aa3a3732601e041e9f64526760bf
• Download URL:
  https://stacks.cdc.gov/view/cdc/147327/cdc_147327_DS1.pdf
• File Type:
  [PDF - 2.54 MB ]